HealthcareEnterprise SoftwareConsumerHardware & SemiconductorsBiotech & Life SciencesAIGamingSocial & Community
Northern Light Venture Capital (NLVC), founded in 2005, is a Chinese venture capital firm that primarily focuses on early-stage technology investments. The firm's strategy involves investing at the intersection of enterprise, healthcare, and consumer opportunities, as well as in TMT (technology, media, and telecom) and advanced technology sectors like AI and IoT, with a significant emphasis on Series A funding rounds.
They made 4 investments in the last 12 months. Average disclosed round size is $57.2M (across 10 rounds with reported amounts).
Portfolio
12
Fund Size
$4.5B
Top Stage
Series B
Last 12 Mo
4
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
12 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| VVibrant Therapeutics | Series C | $61M | Jan 2026 |
 Spiro Medical, Inc. | Series A | $67M | Jan 2026 |
| IiRegene Therapeutics | Series B | $40M | Sep 2025 |
 VOC.AI | Unknown | $15M | Apr 2025 |
 BUD | Series B | $36.8M | May 2022 |
 Stellar Cyber | Series A | $7.1M | Mar 2020 |
| Stellar Cyber | Series A | $13.2M | Feb 2019 |
 APUS Group | Series B | $100M | Jan 2015 |
| BBlack Sesame International Holding | Series D | $218M | — |
 Kaixin001 | Seed | — | — |
 Chukong | Unknown | $14M | — |
 Crossbar, Inc. | Unknown | — | — |
Top Co-Investors
HSG2 shared
New Valley Ventures2 shared
Xiaomi1 shared
Tencent Investment1 shared
SK Group1 shared
Andera Partners1 shared
Omega Funds1 shared
Sherpa Healthcare Partners1 shared
Supernova Invest1 shared
Sequoia China1 shared
Redpoint Ventures1 shared
Chengwei Capital1 shared
SIG1 shared
Sequoia Capital1 shared
GGV Capital1 shared
Sequoia Capital India1 shared
NetEase1 shared
Source Code Capital1 shared
Correlation Ventures1 shared
Tyche Partners1 shared
Last updated: 16 April 2026